TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers Read more about TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study Read more about Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery Read more about Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Read more about Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Extension Study in Primary Distal Renal Tubular Acidosis Read more about Extension Study in Primary Distal Renal Tubular Acidosis
Study Evaluating Subjects With Distal Renal Tubular Acidosis Read more about Study Evaluating Subjects With Distal Renal Tubular Acidosis
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy Read more about Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read more about Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Read more about Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comp Read more about Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comp